Lucid Genomics secures pre-seed funding of €1.3 million to fine-tune their AI models for the identification and diagnosis of biomarkers
The Berlin startup Lucid Genomics, a spin-off of the Max Planck Institute for Molecular Genetics and Charité - Universitätsmedizin Berlin, uses AI-based tools to decode previously undiscovered parts of human DNA. Founders Uirá Souto Melo and Hossein Moeinzadeh have now received 1.3 million euros in pre-seed funding to further develop their…